Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
Abstract The endocannabinoid system has been shown to be involved in various skin functions, such as melanogenesis and the maintenance…
Abstract The endocannabinoid system has been shown to be involved in various skin functions, such as melanogenesis and the maintenance…
Abstract Background: Cannabidiol (CBD) and cannabidiolic acid (CBDA) are reported to have antinociceptive, immunomodulatory and anti‐inflammatory actions. Objectives: To determine…
Abstract Treatment of atopic dermatitis (AD) is challenging due to its complex pathophysiology. Tetrahydrocurcumin (THC) a polyphenolic, colorless compound that…
Abstract 3,4,5-Trihydroxycinnamic acid (THCA) exhibits anti-inflammatory activity in acute or chronic inflammatory disorders, such as acute lung injury and asthma.…
Abstract Atopic dermatitis (AD) is a chronic, inflammatory skin condition, caused by wide genetic, environmental, or immunologic factors. AD is…
Abstract Botanical oils have a long history of traditional use and are routinely applied to skin care. The focus of…
Abstract The endocannabinoid system (ECS) has lately been proven to be an important, multifaceted homeostatic regulator, which influences a wide-variety…